11:54 Feb 06

Alkem Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
5629.00
-33.50 (-0.59%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Alkem Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
5629.00
-33.50 (-0.59%)
11:54 Feb 06
Quality
image/svg+xml

70/100
High Financial Strength

Valuation
image/svg+xml

35/100
Mid Valuation

Technical

53/100
Technically Neutral

Strength

9

Weakness

1

Opportunity

1

Threats

1

18.06 %

ROE %

12.24 %

ROA %

197.47

EPS

1,002.50

BVPS

16.70 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
10634.19 11599.26 12667.58 12964.52 13890.16
Operating Expenses +
8581.27 9989.81 10422.09 10452.37 11079.66
Raw Material
4715.77 4444.47 4923.46 4954.39 5079.93
Increase Decrease in Cost
-535.48 462.37 14.12 -190.13 -24.13
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
1962.71 2131.35 2201.01 2453.92 2644.66
Miscellaneous Expenses
5417.69 5726.72 6541.24 6262.23 3379.2
Operating Profit
2052.92 1609.45 2245.49 2512.15 2810.5
Other Income
162.65 216.08 310.84 493.74 479.13
Depreciation
303.96 310.42 299.3 357.16 379.06
Interest
52.37 107.36 112.41 121.7 129.25
Profit before tax and exceptio..
1859.24 1407.75 2144.62 2527.03 2781.32
Exceptional Items
-14.96 -102.98 -121.49 0 12.93
PBT
1844.28 1304.77 2023.13 2527.03 2768.39
Provision for Taxation
163.96 297.96 211.67 311.03 382.53
Net Profit
1680.32 1006.81 1811.46 2216 2411.72
NET Profit after MI
1645.62 984.17 1795.77 2165.48 2361
EPS
137.63 82.31 150.19 181.11 197.46
Operating Profit Margin (%)
19.3 13.88 17.73 19.38 20.23
Net Profit Margin (%)
15.47 8.48 14.18 16.7 17

Alkem Laboratories Ltd. Shareholding

All Data in Percentage (%)

Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Download Our App On: